Private health insurance: cancer cover

If you are here because a cancer has just been diagnosed, or is being investigated now, take the honest answer first: a policy bought today will not pay for it. The wording this site holds, quoted in full on our page on health insurance and pre-existing conditions, excludes a condition you already have, and moving between insurers does not change that. NHS cancer treatment is free at the point of use, and for a cancer you already know about it stays the route to treatment.

The rest of this page is for the reader who is well and shopping: working out what each policy's cancer section promises before any of it is needed. A broker can set those choices — levels, limits, optional extras — against your own age and circumstances, which no page can do. There is a form on this page that puts you in front of one; it costs nothing and wants a few minutes.

Two things this page will not do. It will not quote a premium: there is no price data behind this site, so any monthly figure here would be invented. And it will not name a best insurer — we hold four cancer clauses and no pricing, which is enough to show where the wording differs and nowhere near enough to rank anybody. Best is the word people search with; the judgement stays yours.

What a policy's cancer section is actually promising

Private medical insurance in the UK is written for conditions that arise after cover starts. Cancer is the benefit buyers look hardest at, because treatment can run for years and the bills do not arrive once — and all four documents behind this page name it specifically: one as a pair of levels, one as a named optional extra, one as sections of the policy book, one as a benefit promise of its own.

What it is not is a cash payment. In general terms private medical insurance pays for treatment, inside the limits written into your own policy, rather than handing you a sum when a diagnosis is made; the product that pays a lump sum on diagnosis is a different one, and we hold no wording for it. Nor, in anything we have read, is cancer cover sold on its own: every document behind this page is a whole private medical insurance policy with cancer inside it. So if you are searching for a cancer payout, or for health insurance just for cancer, establish which product a quote is actually for before you buy.

So the question is not whether a policy covers cancer — all four of our wordings say something about it — but on what terms. Four things carry most of the difference: whether cover comes at a choice of levels, whether a time or financial limit is stated, what conditions attach to drugs and newer therapies, and which part of the wording applies when treatment keeps going rather than resolving.

Four insurers, in their own words

These are the four cancer clauses this site holds, with the document and the day we read it. They are extracts rather than policies: each is the one clause we pulled on this question, so a term missing below is missing from our extract, not from the insurer's wording.

The Exeter: no time or financial limit, in a regulatory summary

"Cancer cover for all stages of cancer once diagnosed, including palliative and terminal treatment, with no time or financial limit."

— The Exeter, Health+ Insurance Product Information Document (October 2025), page 1, read 4 September 2026.

That is the broadest sentence in our evidence and the one to read most carefully. An Insurance Product Information Document is the short regulatory summary, not the policy: the full Policy Document binds, and a limit absent from a summary has not been shown to be absent from the wording behind it. And "once diagnosed" is silent about when the diagnosis happened — the clause says nothing about pre-existing conditions, which policies handle in a different section, so it cannot be read as cover for a cancer you have now.

WPA: conditions attached to targeted therapies, and a minimum excess

"If adding the Cancer Care Optional Extra, Targeted Cancer Therapies/Advanced Therapy Medicinal Products will only be funded when given with curative intent, where not available on the NHS... a minimum excess of £500 will apply."

— WPA, Complete Health Insurance Product Information Document (November 2025), page 1, read 4 September 2026.

Three conditions sit in one sentence: curative intent, unavailability on the NHS, and a minimum £500 excess for adding the extra. That £500 is an excess — money you pay towards a claim, which is a different thing from a premium — and it is the only figure of its kind in our cancer evidence. Note the clause's subject: targeted therapies and advanced therapy medicinal products under one named optional extra. It does not describe what WPA's policy does for cancer treatment generally, and the guide that carries the full wording is not one we have read.

AXA Health: two named levels on one product

AXA's Personal Health membership handbook names two levels of cancer cover, Comprehensive Cancer Cover and NHS Cancer Support, and naming them is all the clause we hold does. Which level a quote is built on is therefore part of both the cover and the price; the tables saying what each pays are not in our extract, so the names are as far as we will take it. The clause is quoted in full, with its page and its source caveat, on our page about an AXA Health online quote. On an AXA quote, which level this is becomes the question to ask before a price means anything.

Saga: three section headings, and no sight of what is under them

What we hold for Saga is not a benefit clause at all. It is a line from the policy book's contents page:

"Your cover for cancer treatment 20. Extended Cancer Cover 23. 7 Recurrent, continuing and long-term treatment 19"

— Saga, Your Policy Book for HealthPlan Super (May 2025), page 2, read 4 September 2026.

All that establishes is that the book has sections with those names at those page numbers. It does not establish what Extended Cancer Cover extends, whether the plan includes it or you pay extra for it, or whether it sits inside or alongside the cancer treatment section: the contents line reads either way, and we are not going to pick a reading. What it is good for is a request — pages 20 and 23 are where Saga's answer lives, and the Saga wording we hold lists the same line with what else it does and does not show.

Set side by side, the four do not line up as more cover and less cover, and anybody who says they do has not read them. They are four different kinds of statement: a summary promising no limit, a condition attached to one group of drugs, a pair of product names, and a table of contents. The real difference is in what each leaves the buyer to decide — a level, an extra, an excess, a hospital list — and a quote can be built more than one way on any of them. Two quotes built differently on those terms is a comparison worth having, and the form on this page hands that job to a broker: one conversation, several insurers, nothing committed at the end of it.

What cancer surgery costs if you pay the hospital yourself

These are self-pay prices: what a private hospital lists for a patient paying out of their own pocket, with no insurer involved. Private healthcare bought outright and private health insurance are different purchases, and these figures belong to the first. They are not premiums and not what cover costs. They are the only cancer figures we hold, and they show how little one headline price tells you.

— Spire Healthcare treatment pages for mastectomy and malignant skin cancer, read 4 September 2026.

The first two rows are the point. Both are a mastectomy, both come from a Spire hospital's own page, and they are listed at £7,301 and £14,900 — so a self-pay price is set hospital by hospital and listing by listing, and we have not read what either package includes. The gap is not evidence that one hospital is dear, only that a figure on a treatment page is not a quotation for your operation.

Then notice what the table leaves out. Every figure above is for an operation, and we hold no price for chemotherapy, radiotherapy, scans, consultations or cancer drugs — which is where the open-ended part of the cost sits, and we will not estimate it. That absence is the argument for reading a policy's limits rather than a price list: ask the hospital what a listed price covers and what happens if more treatment is needed, and ask the insurer which limit applies to each part of the treatment rather than to the surgery alone.

Buying cover when you have had cancer before

A cancer in your past is dealt with by underwriting, which happens before cover starts and turns on your history rather than on the cancer section of the policy. What gets written in or out is decided on your own dates and records, which is why no website, this one included, can tell you in advance.

What does make a difference is the underwriting route. On full medical underwriting you give your history up front and the insurer says what it will exclude before you pay. On a moratorium you are not asked for a full history, a look-back period applies automatically, and whether something was caught is worked out when you claim. We hold no clause setting a look-back or a clear period for cancer, and we will not print a typical one: a number invented here could be the reason somebody buys a policy that will not pay. The clauses that do describe routes and look-backs are quoted on our pages on whether insurers cover pre-existing conditions and what cover is left once a condition is excluded.

The same answer covers the narrower searches, because the wording does not distinguish between them: breast cancer, prostate cancer or anything else in your history is handled as history, not as a cancer type. If you want it priced, have one history put to several insurers at once and compare what each writes into the policy, instead of applying once and reading the first answer as the market's. That is where the form on this page earns its keep: your details go over once, to an FCA-authorised broker — which this site is not — who can take one history to more than one underwriter.

When the question is about a particular condition

Some of the searches that reach this site are not about cancer at all: whether epilepsy treatment is covered under health insurance, whether pancreatitis is covered in health insurance, whether anaemia is. The framework is the same for all of them, and it rests on two questions.

First, when did it start? A condition that pre-dates the policy is pre-existing, whatever it is called. Second, how does the wording treat it? Private medical insurance is generally written for acute conditions, which in policy language means ones that treatment is expected to resolve rather than manage indefinitely; a long-term condition is generally dealt with under different rules, or outside the policy altogether, as a separate matter from whether it pre-dates cover.

We hold no clause naming epilepsy, pancreatitis or anaemia, so this page will not tell you any insurer covers or excludes them, and nothing here is medical information: how a condition should be treated is not a question for an insurance page. What you can do is ask an insurer, in writing, how its wording treats the condition you are asking about, and ask for its own definitions of acute and chronic, which are the words doing the work. That is also the answer on prostate cancer treatment: none of the four wordings we hold singles out individual cancers by site, so what decides it is timing, the level or extra you hold, and the limits.

What we could not establish, and the questions that close the gap

Our evidence runs out well before a buying decision does. We have not read what AXA's two levels pay, what is under Saga's cancer headings, what The Exeter's full Policy Document says about limits, or what WPA covers outside the Cancer Care extra. None of those gaps is an insurer's silence — all four publish more than we have quoted — and each is a question somebody can answer in writing before you pay:

1. Which level or extra is this quote built on, and what does it pay? If cancer cover comes at more than one level, get both priced rather than assuming the quote shows the better one.
2. Is there a time or financial limit, and what does it attach to? A limit can sit on the condition, on a year, on a benefit line or on a drug list.
3. How are cancer drugs and targeted therapies covered, and does a separate excess apply? WPA's clause shows that both a condition and an excess can attach to this one benefit.
4. What happens if treatment continues for years? Ask which section applies when treatment is continuing rather than one-off, and read it.
5. Which hospitals, and which specialists? Ask which hospital list the quote assumes before comparing it with another.
6. If cancer is in your history, what is the look-back, and can an exclusion lift? Ask on your own dates, in writing, and keep the answer with the policy.

Quick answers on cancer cover

Does private health insurance cover cancer?

Cancer that develops after your policy starts is addressed by all four wordings we hold, and it is one of the headline benefits UK policies are sold on. What differs is the terms — levels, limits, drug conditions, excesses. A cancer you already have is excluded as pre-existing.

Can I take out a policy if I have cancer now, or am being investigated?

Not for that cancer. A condition you have, or are under investigation for, is a pre-existing condition on the wording this site holds, and a new policy will not pay for its treatment. NHS treatment is free at the point of use and is the route for a diagnosis you already have.

Can I get private health insurance after cancer?

Often yes as a member, with the history handled by underwriting — but whether the past cancer and anything related to it is excluded, and for how long, is decided on your own records. We hold no clause stating a look-back or clear period for cancer, so ask each insurer for its answer on your dates.

Does health insurance cover prostate cancer treatment?

None of our four wordings names individual cancers by site, so there is no separate prostate answer to read off a document. What decides it is the same as for any cancer: whether it was diagnosed before the policy started, which level or extra you hold, and what limits apply.

Does private health insurance cover chemotherapy?

Not one of our four clauses uses the word chemotherapy, so we cannot tell you either way. The clause that comes closest is WPA's, and it is about targeted therapies and advanced therapy medicinal products under an optional extra, with conditions of its own. Ask for the section of the wording that deals with drug treatment.

Is cancer screening covered?

We hold no clause on screening or health assessments, so we will not say whether any insurer includes it. Whether you should be screened is a medical question and not one for this page; whether a policy pays for screening is a question for the insurer, and worth asking separately from treatment cover.

Is there free health insurance for cancer patients?

No. Private cover is bought in advance, and we know of no free private policy for people who are already ill. What is free at the point of use is NHS cancer treatment, which is not insurance but is the route to care for a diagnosis you already have.

Which insurer has the best cancer cover?

We do not rank insurers, and with four clauses and no pricing nobody honestly could. What you can compare is wording against wording: whether cover comes at levels, whether a limit is stated, what conditions attach to drug treatment, and what each company will confirm in writing for your own circumstances.

Where to go from here

If you are well and deciding, the move that gets you furthest is having the same cover priced more than one way — levels, extras and excesses included — so the differences above turn into numbers you can weigh. One form on this page, one call back from the broker we introduce, and cover priced on more than one of these wordings; the six questions above stay yours to ask. If you are dealing with a diagnosis now, nothing here is what you need, and the NHS is.